Shots:

• Evotec to apply its drug discovery & development capabilities plus will utilize Vifor Pharma’s platform for creating pipeline of nephrology program and with the completion of clinical trials evaluating products Vifor Pharma will in-license them for registration and commercialization while expanding its nephrology pipeline
• Vifor to fund €25M for pre-clinical development while the companies will be sharing all the clinical and commercial costs on successful candidates with opt-out rights at each stage based on a predetermined profit share arrangement
• The agreement will involve the combination of Evotec’s drug discovery capabilities with Vifor Pharma’s development and commercialization expertise in Nephrology and will focus on patient data-driven target identification pursing medication for treating kidney disorders

Click here to­ read full press release/ article | Ref: Evotec | Image: Forbes